Berlin-based YOU(th) Health Tech has raised $4.5 million to scale a platform that turns smartphones into preventive health screening tools – using face videos, voice recordings, skin and eye images, typing patterns, and step data to assess more than 50 digital biomarkers across over 10 organ systems in under two minutes.
The round was led by Callisto Health with participation from caesar., adesso Ventures, Antler, Moonstone, and 1024 Ventures. Angel investors include Alan founder Jean-Charles Samuelian and HomeToGo CEO Patrick Andrae. The funding will go primarily toward expanding engineering, data science, and medical research teams.
YOU(th) is going to market via a B2B2C model and has already signed more than 20 contracts with clinics and health insurance providers. The platform estimates indicators including blood pressure, oxygen saturation, respiratory symptoms, proxies for glucose and cholesterol, cognitive age, skin condition, and hydration levels – all without specialized hardware, needles, or clinic visits.
“Everyone talks about prevention, yet only about 8% screen at the optimal frequency because time, cost, and friction get in the way,” said founder and CEO Filippo Nigro. “We remove those barriers by turning everyday phone behavior – selfies, voice, typing – into passive health screening, seamlessly connected to real healthcare.”
The founding team brings technical depth: Nigro is a former product lead at HomeToGo, COO Johannes Kraus previously built a machine-learning marketplace for health insurers adopted by Munich Re, and CTO Yuriy Dushin is a biostatistician and digital biomarker researcher.
Clinical validation and integration into reimbursed care pathways will be the key hurdles as YOU(th) scales – but with insurer contracts already in place, the company has early signals that the model resonates with the payers who would ultimately need to adopt it.
